LEQEMBI® (lecanemab) EISAI HK Reg. No. HK-68289 (03 Jul, 2024) & HK-68290 (03 Jul, 2024) Composition: 3 LEQEMBI® is an amyloid beta-directed antibody with the active ingredient lecanemab-irmb. It is administered as an intravenous infusio...

Triplixam ® ( perindopril arginine/indapamide/amlodipine ) 5 Servier Perindopril is an angiotensin converting enzyme inhibitor (ACE inhibitor) Indapamide is a thiazide diuretic Amlodipine is a calcium-channel blocker (CCB) Compositio n : Availa...